<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="1-part\PMC7358258\results\search\disease\results.xml">
  <result pre="one of the most common causes of outbreaks of acute" exact="gastroenteritis" post="(AGE) and sporadic acute diarrhea episodes in subjects of"/>
  <result pre="causes of outbreaks of acute gastroenteritis (AGE) and sporadic acute" exact="diarrhea" post="episodes in subjects of any age. In 2016 the"/>
  <result pre="and calculate whether systematic vaccination can be cost effective. acute" exact="gastroenteritis" post="GI strain GII strain norovirus norovirus vaccine fig-count: table-count:"/>
  <result pre="one of the most common causes of outbreaks of acute" exact="gastroenteritis" post="(AGE) and sporadic acute diarrhea episodes in subjects of"/>
  <result pre="causes of outbreaks of acute gastroenteritis (AGE) and sporadic acute" exact="diarrhea" post="episodes in subjects of any age (1). The development"/>
  <result pre="with low diarrhea-related mortality (19%) (6â€&quot;8). The incidence of NoV" exact="diarrhea" post="is, in contrast, slightly lower in high-mortality developing nations"/>
  <result pre="due to the lack of adequate infection control measures. NoV" exact="diarrhea" post="is diagnosed in patients of any age. Studies carried"/>
  <result pre="respectively. Moreover, more than 3% of patients with a NoV" exact="diarrhea" post="episode can die, as shown by the evidence that"/>
  <result pre="to years. This chronicity leads to prolonged virus shedding and" exact="gastrointestinal disease" post="that can become increasingly debilitating and lead to death"/>
  <result pre="antigenic drift plays a role, as in the case of" exact="influenza" post="virus, to reduce protection evoked by previous infections with"/>
  <result pre="frequently used: the baculovirus replicon system and the Venezuelan equine" exact="encephalitis" post="replicon system (42, 43). Both are relatively inexpensive and"/>
  <result pre="Research Centers Vaccines combining NoV VPI P domain with RV," exact="hepatitis" post="E, influenza and astrovirus in order to obtain extensive"/>
  <result pre="Vaccines combining NoV VPI P domain with RV, hepatitis E," exact="influenza" post="and astrovirus in order to obtain extensive protection. Studies"/>
  <result pre="not reach statistical significance. Severe, moderate or mild vomiting and" exact="diarrhea" post="were evidenced in vaccinees at rates of 0, 6,"/>
  <result pre="utilized. Subsequent challenge with GII.4 revealed that the risk of" exact="diarrhea" post="was lower in vaccinated animals than in those with"/>
  <result pre="allowing vaccines targeting multiple potential infections. Combination vaccines for RV," exact="hepatitis" post="E, influenza and astrovirus have been considered. Insertion of"/>
  <result pre="targeting multiple potential infections. Combination vaccines for RV, hepatitis E," exact="influenza" post="and astrovirus have been considered. Insertion of RV VP8"/>
  <result pre="in mice (67). Similar positive results were found when the" exact="influenza" post="M2e gene was inserted in the NoV VPI P"/>
  <result pre="Disorders (WAidid-2020-01). References References 1.DolinR. Norwalk agent-like particles associated with" exact="gastroenteritis" post="in human beings. J Am Vet Med Assoc. (1978)"/>
  <result pre="173:615â€&quot;19. 100481 2.PuustinenLBlazevicVSalminenMHamalainenMRasanenSVesikariT. Noroviruses as a major cause of acute" exact="gastroenteritis" post="in children in Finland, 2009â€&quot;2010. Scand J Infect Dis."/>
  <result pre="Pathog Dis. (2013) 10:639â€&quot;48. 10.1089/fpd.2012.138923659355 13.HallAJRosenthalMGregoricusNGreeneSAFergusonJHenaoOLet al.. Incidence of acute" exact="gastroenteritis" post="and role of norovirus, Georgia, USA, 2004â€&quot;2005. Emerg Infect"/>
  <result pre="14.KarstenCBaumgarteSFriedrichAWvon EiffCBeckerKWosniokWet al.. Incidence and risk factors for community-acquired acute" exact="gastroenteritis" post="in north-west Germany 2004. Eur J Clin Microbiol Infect"/>
  <result pre="control. Infect Dis Clin North Am. (2017) 31:839â€&quot;70. 10.1016/j.idc.2017.07.01228911830 20.BokKGreenKYNorovirus" exact="gastroenteritis" post="in immunocompromised patients. Norovirus in immunocompromised patients. Oncol Nurs"/>
  <result pre="Infect Dis. (2018) 31:422â€&quot;32. 10.1097/QCO.000000000000047630102614 33.ParrinoTASchreiberDSTrierJSKapikianAZBlacklowNR. Clinical immunity in acute" exact="gastroenteritis" post="caused by norwalk agent. N Engl J Med. (1977)"/>
  <result pre="151:99â€&quot;105. 10.1093/infdis/151.1.992981278 36.JohnsonPCMathewsonJJDuPontHLGreenbergHB. Multiple-challenge study of host susceptibility to Norwalk" exact="gastroenteritis" post="in US adults. J Infect Dis. (1990) 161:18â€&quot;21. 10.1093/infdis/161.1.182153184"/>
  <result pre="43.BaricRSYountBLindesmithLHarringtonPRGreeneSRTsengFCet al.Expression and self-assembly of norwalk virus capsid protein from" exact="venezuelan equine encephalitis" post="virus replicons. J Virol. (2002) 76:3023â€&quot;30. 10.1128/JVI.76.6.3023-3030.200211861868 44.FangHTanMXiaMWangLJiangX. Norovirus"/>
  <result pre="and self-assembly of norwalk virus capsid protein from venezuelan equine" exact="encephalitis" post="virus replicons. J Virol. (2002) 76:3023â€&quot;30. 10.1128/JVI.76.6.3023-3030.200211861868 44.FangHTanMXiaMWangLJiangX. Norovirus"/>
  <result pre="particle vaccine provided partial cross-variant protection against human GII.4 norovirus" exact="diarrhea" post="in gnotobiotic pigs. J Virol. (2014) 88:9728â€&quot;43. 10.1128/JVI.01249-1424920797 67.TanMFangPChachiyoTXiaMHuangPFangZet"/>
  <result pre="(2008) 382:115â€&quot;23. 10.1016/j.virol.2008.08.04718926552 68.XiaMTanMWeiCZhongWWangLMcNealMet al.. A candidate dual vaccine against" exact="influenza" post="and noroviruses. Vaccine. (2011) 29:7670â€&quot;77. 10.1016/j.vaccine.2011.07.13921839795 69.WangXKuZDaiWChenTYeXZhangCet al.. A"/>
 </snippets>
</snippetsTree>
